Capa, Estelito .

HRN: 06-89-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2022
CEFUROXIME 1.5GM (VIAL)
10/09/2022
10/16/2022
IV
1.5 G
Q8H
Multiple Abrasions, Lacerated Wound Inferior Lip Secondary To VA
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: